These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39297217)

  • 1. Inhaled Medications for Maintenance Therapy in Pediatric Noncystic Fibrosis Bronchiectasis.
    Harvath Gray EM; Pettit RS; Engdahl S
    Ann Pharmacother; 2024 Sep; ():10600280241279602. PubMed ID: 39297217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for bronchiectasis: an overview of Cochrane systematic reviews.
    Welsh EJ; Evans DJ; Fowler SJ; Spencer S
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010337. PubMed ID: 26171905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
    Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E
    J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705
    [No Abstract]   [Full Text] [Related]  

  • 8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic options for noncystic fibrosis bronchiectasis.
    Yap VL; Metersky ML
    Curr Opin Infect Dis; 2015 Apr; 28(2):171-6. PubMed ID: 25692269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents.
    Lee E; Kim K; Jeon YH; Sol IS; Kim JD; Min TK; Hwang YH; Cho HJ; Suh DI; Kim HS; Kim YH; Woo SI; Lee YJ; Jung S; Yang HJ; Jang GC
    Clin Exp Pediatr; 2024 Sep; 67(9):418-426. PubMed ID: 38271987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment options for bronchiectasis.
    Metersky ML
    Ther Adv Respir Dis; 2010 Apr; 4(2):93-9. PubMed ID: 20388725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ; Soler Cataluña JJ; Serra PC
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiectasis and inhaled tobramycin: A literature review.
    Elborn JS; Blasi F; Haworth CS; Ballmann M; Tiddens HAWM; Murris-Espin M; Chalmers JD; Cantin AM
    Respir Med; 2022 Feb; 192():106728. PubMed ID: 34998112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study.
    Wei P; Yang JW; Lu HW; Mao B; Yang WL; Xu JF
    Medicine (Baltimore); 2016 Oct; 95(42):e5116. PubMed ID: 27759640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
    Sangiovanni S; Morales EI; Fernández-Trujillo L
    Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
    Dhand R
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antibiotics for bronchiectasis.
    Felix LM; Grundy S; Milan SJ; Armstrong R; Harrison H; Lynes D; Spencer S
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012514. PubMed ID: 29889304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.